Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
Vidhi Shukla, Assistant Professor at B. K. Mody Government Pharmacy College, Rajkot, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Pharmaceutical Sciences, adding:
“Excited to share another milestone in my research journey!
I am pleased to announce the publication of our research article in the International Journal of Pharmaceutical Sciences.
Title: ‘Evaluation of Anti-Coagulant Activity of Ficus racemosa Bark Extract in Rats’
This study investigates the anticoagulant potential of the ethanolic extract of Ficus racemosa bark through both in vitro and in vivo evaluations.
The findings demonstrated significant effects on key coagulation parameters, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), highlighting the potential of plant-derived bioactive compounds as promising candidates for further pharmacological investigation.
Writing and contributing to this research was both challenging and rewarding. It provided an opportunity to explore the pharmacological potential of medicinal plants while strengthening my understanding of experimental research, anticoagulant evaluation, and the role of natural products in drug discovery.
I am grateful to everyone who supported and contributed to this research journey.”
Title: Evaluation of Anti-Coagulant Activity of Ficus racemosa Bark Extract in Rats
Authors: Vidhi Shukla, Rachna Katbamna, Dakshkumar Patel, Ravi Manek, Jignesh Patel, Malay Rathod, Manisha Kalariya
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian